Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Molecular Biology

Background:

• The EP2 receptor is a G protein-coupled receptor involved in various physiological processes.
• Developing biased agonists that selectively activate specific signaling pathways is a key goal in drug discovery.
• Compound 1 is a novel G protein-biased EP2 agonist with potential therapeutic applications.

Purpose of the Study:

• To improve the G protein activity of compound 1.
• To gain a deeper understanding of the structure-functional selectivity relationship (SFSR) of EP2 agonists.
• To identify optimized EP2 agonists with enhanced G protein bias.

Main Methods:

• Systematic modification of substituents on the phenyl ring of compound 1.
• Inversion of the hydroxyl group on the cyclopentane moiety.
• Assessment of G protein activity and beta-arrestin recruitment for synthesized compounds.

Main Results:

• Compound 9, derived from optimization and hydroxyl group inversion, exhibited a 100-fold increase in G protein activity compared to compound 1.
• No significant increase in beta-arrestin recruitment was observed for compound 9.
• Structure-functional selectivity relationship studies indicated that specific meta and para substituents on the phenyl ring are critical for achieving functional selectivity.

Conclusions:

• The optimized EP2 agonist, compound 9, demonstrates significantly improved G protein activity and functional selectivity.
• The study highlights the importance of specific phenyl ring substitutions and hydroxyl group configuration in modulating EP2 receptor signaling.
• These findings provide valuable insights for the rational design of novel biased agonists targeting the EP2 receptor for therapeutic purposes.